Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .

Name: Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .
Start: 2025-09-11
End: 2027-08-27
Location: AOK Niedersachsen. Die Gesundheitskasse.

AOK Niedersachsen. Die Gesundheitskasse. Germany has Released a tender for Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea . in Pharmaceuticals. The tender was released on Sep 10, 2025.

Country - Germany

Summary - Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .

Deadline - Aug 27, 2027

GT reference number - 117611285

Product classification - General anti-infectives for systemic use and vaccines

Organization Details:

Address - Germany

Contact details - 565656565

Tender notice no. - 76454545

GT Ref Id - 117611285

Document Type - Tender Notices

Login

Notice Details and Documents:

Description - notice_title: Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .local title:: Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Budesonid (ausgenommen Inhalativa und mindestens mit einer Zulassung für die Indikation chronisch entzündliche Darmerkrankung) (ATC-Code: A07EA.local description: : Abschluss eines nicht exklusiven Rabattvertrages nach § 130a Abs. 8 SGB V zu Arzneimitteln mit dem Wirkstoff Budesonid (ausge

Gt Ref Id - 117611285

Deadline - Aug 27, 2027

Login

Share

Similar Tenders :

Summary:

Clindamycin / Dalacin 15 Mg / Ml

Summary:

Huj Cbam 311/2022 Pfizer, S.L. Framework Agreement With A Single Company, By Lot, Which Sets The Conditions For The Supply Of Successive Tract And Unit Price For Acquisition Of Conjugated Vaccine Against The Meningococcus-C And Combined Vaccine Against Measles, Rubella And Clippartitis (Triple Viral), Destined For The Andalusian Vaccination Program (Pva).

Summary:

Huj Cbam 311/2022 Merk Sharp & Dohme De España, S.A. Framework Agreement With A Single Company, By Lot, Which Sets The Conditions For The Supply Of Successive Tract And Unit Price For Acquisition Of Conjugated Vaccine Against The Meningococcus-C And Combined Vaccine Against Measles, Rubella And Clippartitis (Triple Viral), Destined For The Andalusian Vaccination Program (Pva).

Summary:

Fourth Contract Based On Am 414/2022 Almería

Summary:

Cc: +6.6Ii45Ta. Cbam 1204/2021 Pfizer. Supply Of Successive Tract And Unit Price Of The Tetravalent Conjugate Vaccine (A, C, W, Y) In Front Of The Meningococcus, For The Andalusian Vaccination Program

Completion Of A Non-Exclusive Discount Contract According To Section 130A (8) Sgb V For Medicinal Products With The Active Ingredient Budesonide (Except Inhalativa And At Least With A Admission To The Indication Of Chronic Inflammatory Bowel Disease) (Atc Code: A07Ea .

Organization Details:

Notice Details and Documents:

Create Account